MediOrbis, a multi-specialty telemedicine and telehealth company providing specialty and chronic disease management (CDM) programs, announces the successful pilot and market introduction of MediSteps, the first-of-its kind physician-managed and technology-driven weight loss and preventive health program that combines medical weight loss with access to virtual physician consults 24/7. Providing consumers with direct access to comprehensive physician management, in addition to a dedicated app and web access, multilingual services, medications as needed and flexible pricing options, MediSteps differentiates itself in quality and value for patients with obesity, diabetes, hypertension, hyperlipidemia and cardiovascular disease.

Read our white paper here.

The successful pilot demonstrated key results including:

  • Significant weight loss in all patients (up to 8.5 lbs/month)
  • Improved diabetes control, including lowering of hemoglobin A1c(HbA1c) (1.2% in 8 weeks) and cessation of oral hypoglycemics
  • Improved energy and health consciousness
  • High satisfaction with the engagement platform and clinical staff (rated 10/10).

“MediSteps is an excellent program for people looking to change their lifestyle, improve health and modify medical risk factors,” says Dr. Jonathan Wiesen, M.D., founder and chief medical officer of MediOrbis. “Exceptional results of our pilot program demonstrate 5-10 lb. weight loss per month. Even modest weight loss can have an important health impact, such as a 5-10% decrease in blood pressure, lower cholesterol and cardiovascular disease risk profile, improved joint health and 12% reduction in cancer risk. A recent study demonstrated that obesity is especially dangerous for men and younger patients who contract COVID-19, and that obesity stood out from racial, ethnic, or socioeconomic disparities when isolated from those factors.”

MediSteps physicians manage all aspects of the program, including overseeing the weight loss interventions while simultaneously managing medications and prescriptions. A top-tier telehealth platform streamlines all communications and integrates a tool set with powerful software that includes artificial intelligence and predictive analytics that go beyond the standard equations to eliminate gaps in care. All platforms are HIPAA-compliant, secure with encryption and available on a mobile app that offers a simple, intuitive and convenient, user-friendly interface.

Joshua Penn, MD, medical director, MediSteps and highly respected cardiologist with over 30 years of preventive cardiology experience, says, “Weight loss, along with the metabolic management that we do as part of our program, has consistently shown remarkable success in reducing, and in many cases eliminating, the need for insulin and other costly diabetes medications. This leads to fewer ER visits and hospitalizations and can make a meaningful reduction in risk markers within three months– including HbA1c, reduction in weight, body mass index and body fat composition.”

In addition to these benefits, which usually manifest within weeks of starting, patients who successfully complete the program have increased exercise capacity and well-being, reduction in depressive symptoms and lower fatty liver content.

MediSteps and Remote Patient Monitoring (RPM) services, offered in partnership with DarioHealth, add to MediOrbis’ CDM capabilities establishing the company as a leader in physician managed chronic disease care.

About MediOrbis

MediOrbis is a multi-specialty telemedicine and telehealth company that is shattering the barriers of traditional medicine and extending the reach of specialized clinical care and chronic disease management to its global customer base. Recognized for efficiency and cost-effectiveness to meet the needs of providers, payers and healthcare systems, MediOrbis combines AI-powered software with a network of the world’s most outstanding specialty physicians to deliver expert telemedicine services in virtually any field of medicine, clinical care or diagnostics. Visit: www.mediorbis.com.

close

Subscribe to Our Newsletter (coming soon)

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.